David Lazar's OTC SPAC's/CUSTODIAN Plays

[Potse]

EAIN($2.25)...finished accumulating core position......

I bought some more blocks of shares today at $2.24 and $2.25 to finish building a core position in the EAIN shell. Have had very little luck in my numerous attempts over the last few weeks to pick up shares on my high-bid orders. But today a little more size appeared on (or near) the ask, so I hit those to secure some more shares.

I think the RM target (Mirror Biologics) has the potential of reaching a pretty sizable market capitalization based on the things/sector it is involved in. It would seem likely to me that this reverse merger will probably attract some institutional interest or investors with pretty deep pockets.

It should be very interesting to see what the structure of this reverse merger will be like. It looks like David Lazar will receive 2.4+M shares when the RM is completed. From the "subsequent events" section of the quarterly report filed 2 weeks ago......

On October 1, 2020 the holder of the Series A Preferred sold them to a third party. That Agreement provides for the acquisition of the Shares by Buyer for a total purchase price of (i) U.S. Dollars ($100,000.00), payable in the form of a promissory note, and (ii) 2,443,052 shares of restricted common stock of the Buyer, to be issued upon the effectiveness of the reverse merger.